NCT06353256

Brief Summary

United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal community health worker intervention for Black postpartum patients with preeclampsia (PE) and other adverse pregnancy outcomes (APOs). Investigators will partner with a community-based organization that trains and deploys community health workers. Investigators will test an intervention for urban and rural Black postpartum patients with APOs to 1) enhance blood pressure control postpartum and 2) promote long-term cardiovascular disease prevention for this underserved population. This pilot study will determine if randomizing and implementing a community health worker intervention tailored to pregnant people experiencing preeclampsia is feasible and found to be acceptable by participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

September 3, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

March 28, 2024

Last Update Submit

September 29, 2025

Conditions

Keywords

community health workersadverse pregnancy outcomespreeclampsia

Outcome Measures

Primary Outcomes (1)

  • Acceptability

    Participant satisfaction with postpartum support received as part of the study (scaled from 1 to 10).

    12 weeks

Secondary Outcomes (3)

  • Patient satisfaction with CHW intervention

    6-12 weeks postpartum

  • Secondary Outcome Measure: Primary Care Visit Scheduled

    6-12 weeks postpartum

  • Secondary Outcome Measure: Mean Blood Pressure

    6-12 weeks postpartum

Study Arms (2)

Usual Care

EXPERIMENTAL

Usual postpartum care

Behavioral: usual postpartum care

Usual care and community health worker intervention

EXPERIMENTAL

Usual postpartum care and community health worker visits and support

Behavioral: usual postpartum care + community health worker intervention

Interventions

Usual clinical and educational postpartum care

Usual Care

participants will receive routine care and also community health worker support and visits.

Usual care and community health worker intervention

Eligibility Criteria

Age16 Years - 56 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Self Identifies as Black
  • Between 16-56 years old
  • Experiencing adverse pregnancy outcomes defined as hypertensive disorders of pregnancy, preterm birth, placental abruption, pregnancy loss (loss at greater or equal to 14 weeks gestation), gestational diabetes, delivering a small for gestational age infant
  • Planning to deliver at UAB Hospital
  • Speaks and writes in English

You may not qualify if:

  • Declines Randomization
  • Speaks or writes in languages other than English
  • Currently incarcerated
  • Previously enrolled in P3OPPY

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UAB Medicine

Birmingham, Alabama, 35205, United States

Location

The University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

Related Publications (5)

  • Centers for Disease Control and Prevention.Maternal Mortality by State, 2018. US Department of Health and Human Services. National Center for Health Statistics.

    BACKGROUND
  • Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA, Gunderson EP, Stuart JJ, Vaidya D; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021 May 4;143(18):e902-e916. doi: 10.1161/CIR.0000000000000961. Epub 2021 Mar 29.

    PMID: 33779213BACKGROUND
  • Leitao S, Manning E, Greene RA, Corcoran P; Maternal Morbidity Advisory Group*. Maternal morbidity and mortality: an iceberg phenomenon. BJOG. 2022 Feb;129(3):402-411. doi: 10.1111/1471-0528.16880. Epub 2021 Sep 23.

    PMID: 34455672BACKGROUND
  • Minehart RD, Bryant AS, Jackson J, Daly JL. Racial/Ethnic Inequities in Pregnancy-Related Morbidity and Mortality. Obstet Gynecol Clin North Am. 2021 Mar;48(1):31-51. doi: 10.1016/j.ogc.2020.11.005.

    PMID: 33573789BACKGROUND
  • Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, Vermunt JV, August P; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease, Kidney in Heart Disease Science Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 Feb;79(2):e21-e41. doi: 10.1161/HYP.0000000000000208. Epub 2021 Dec 15.

    PMID: 34905954BACKGROUND

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Jesse E Rattan

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 9, 2024

Study Start

September 3, 2024

Primary Completion

June 2, 2025

Study Completion

June 2, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations